Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
The Canadian Journal of Cardiology|September 8, 2006
Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery diseaseJacques Genest
The Canadian Journal of Cardiology|August 17, 2004
Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?Jacques Genest
Cardiology in Review|January 16, 2002
Genetics and prevention: a new look at high-density lipoprotein cholesterolJacques Genest
The Canadian Journal of Cardiology|April 14, 2010
C-reactive protein: risk factor, biomarker and/or therapeutic target?Jacques Genest
BBA Clinical|December 18, 2015
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskAnouar Hafiane, Jacques Genest
Atherosclerosis|February 17, 2019
HDL cholesterol and ASCVD risk stratification: A debatePhilip Barter, Jacques Genest
Annals of Clinical and Laboratory Science|December 15, 2015
HDL-Mediated Cellular Cholesterol Efflux Assay MethodAnouar Hafiane, Jacques Genest
Expert Review of Cardiovascular Therapy|March 9, 2013
HDL-C: clinical equipoise and vascular endothelial functionSteven Campbell, Jacques Genest
European Journal of Preventive Cardiology|April 9, 2014
Inflammation modulation and cardiovascular disease preventionZuhier Awan, Jacques Genest
Atherosclerosis|January 28, 2017
ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesisAnouar Hafiane, Jacques Genest
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
The Canadian Journal of Cardiology|September 8, 2006
Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery diseaseJacques Genest
The Canadian Journal of Cardiology|August 17, 2004
Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?Jacques Genest
Cardiology in Review|January 16, 2002
Genetics and prevention: a new look at high-density lipoprotein cholesterolJacques Genest
The Canadian Journal of Cardiology|April 14, 2010
C-reactive protein: risk factor, biomarker and/or therapeutic target?Jacques Genest
BBA Clinical|December 18, 2015
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskAnouar Hafiane, Jacques Genest
Atherosclerosis|February 17, 2019
HDL cholesterol and ASCVD risk stratification: A debatePhilip Barter, Jacques Genest
Annals of Clinical and Laboratory Science|December 15, 2015
HDL-Mediated Cellular Cholesterol Efflux Assay MethodAnouar Hafiane, Jacques Genest
Expert Review of Cardiovascular Therapy|March 9, 2013
HDL-C: clinical equipoise and vascular endothelial functionSteven Campbell, Jacques Genest
European Journal of Preventive Cardiology|April 9, 2014
Inflammation modulation and cardiovascular disease preventionZuhier Awan, Jacques Genest
Atherosclerosis|January 28, 2017
ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesisAnouar Hafiane, Jacques Genest
Pageof 22